Portfolio Tag: James Oliviero

James Oliviero, CEO and president of Checkpoint Therapeutics

Get to Know James Oliviero, CEO and President of Checkpoint Therapeutics

September 27, 2021

BioSpace recently spoke with James Oliviero, CEO and president at Checkpoint Therapeutics, an immuno-oncology, late-stage development company.

Read the post

Follow us to receive new posts from Science Says

Subscription Form (#2)
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram